Wholesale Tirzepatide Pens - GLP-1 Receptor Agonist for Obesity Research

Tirzepatide pens contain a lyophilized powder formulation of the triple agonist peptide that targets glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This pharmaceutical grade compound demonstrates high binding affinity with EC50 values of 5.79 nM (GCGR), 0.0643 nM (GIPR), and 0.775 nM (GLP-1R) in human receptors.

The Tirzepatide pens formulation shows significant activity in metabolic regulation studies, particularly in glucose tolerance improvement and weight management research. When activated through the glucagon receptor pathway, it demonstrates notable effects on energy expenditure and body weight reduction.

Our Tirzepatide pens are supplied as sterile lyophilized powder in sealed vials under controlled conditions to ensure stability and purity. The product is intended for research applications only and not for human consumption.